Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.640
-0.120 (-6.82%)
At close: Sep 30, 2026, 4:00 PM EDT
1.720
+0.080 (4.88%)
After-hours: Sep 30, 2026, 7:40 PM EDT
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 12 employees as of December 31, 2025. The number of employees increased by 2 or 20.00% compared to the previous year.
Employees
12
Change (1Y)
2
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,119,849
Market Cap
5.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 2 | 20.00% |
| Dec 31, 2024 | 10 | -3 | -23.08% |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | 0 | - |
| Dec 31, 2021 | 15 | 1 | 7.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 38 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| NuCana | 12 |
| Lexaria Bioscience | 7 |
| Enveric Biosciences | 6 |
| Kairos Pharma | 4 |
| Creative Medical Technology Holdings | 4 |
PCSA News
- 13 days ago - Processa Pharmaceuticals Slides: Corporate presentation - Filings
- 19 days ago - Processa Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 20 days ago - Processa Pharmaceuticals Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 4 weeks ago - Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Processa Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 2 months ago - Processa buys Vidya Therapeutics, raises $200 million for drug trials - Reuters
- 2 months ago - Processa Pharmaceuticals Transcript: M&A announcement - Transcripts
- 2 months ago - Processa Pharmaceuticals Press release: M&A announcement - Filings